Insulin API Market Report

Global and Region Insulin API Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：145
  • REPORT CODE：GMM938503
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Insulin API market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Insulin APImarket, defines the market attractiveness level of Insulin API market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Insulin API industry, describes the types of Insulin API market, the applications of major players and the market size, and deeply analyzes the current situation of the global Insulin API market and the development prospects and opportunities of Insulin API industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Insulin API market in Chapter 13.

    By Player:

    • Eli Lilly

    • Tonghua Dongbao

    • Sanofi-Aventis

    • Biocon

    • Gan & Lee Pharmaceuticals

    • United Laboratory

    • Yichang HEC Changjiang Pharmaceutical

    • Amphastar

    • Bioton

    By Type:

    • Regular Human Insulin

    • Insulin Analogue

    By End-User:

    • Short Acting

    • Intermediate Acting

    • Long Acting

    • Pre-mix Insulin

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Insulin API Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Insulin API Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Insulin API Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Insulin API Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Insulin API Market Analysis and Outlook to 2022

    • 7.1 Global Insulin API Consumption (2017-2022)

    • 7.2 United States Insulin API Consumption (2017-2022)

    • 7.3 Europe Insulin API Consumption (2017-2022)

    • 7.4 China Insulin API Consumption (2017-2022)

    • 7.5 Japan Insulin API Consumption (2017-2022)

    • 7.6 India Insulin API Consumption (2017-2022)

    • 7.7 South Korea Insulin API Consumption (2017-2022)

    8 Region and Country-wise Insulin API Market Analysis and Outlook to 2028

    • 8.1 Global Insulin API Consumption Forecast (2022-2028)

    • 8.2 United States Insulin API Consumption Forecast (2022-2028)

    • 8.3 Europe Insulin API Consumption Forecast (2022-2028)

    • 8.4 China Insulin API Consumption Forecast (2022-2028)

    • 8.5 Japan Insulin API Consumption Forecast (2022-2028)

    • 8.6 India Insulin API Consumption Forecast (2022-2028)

    • 8.7 South Korea Insulin API Consumption Forecast (2022-2028)

    9 Global Insulin API Market Outlook by Types and Applications to 2022

    • 9.1 Global Insulin API Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Regular Human Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Insulin Analogue Consumption and Growth Rate (2017-2022)

    • 9.2 Global Insulin API Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Short Acting Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Intermediate Acting Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Long Acting Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Pre-mix Insulin Consumption and Growth Rate (2017-2022)

    10 Global Insulin API Market Outlook by Types and Applications to 2028

    • 10.1 Global Insulin API Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Regular Human Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Insulin Analogue Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Insulin API Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Short Acting Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Intermediate Acting Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Long Acting Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Pre-mix Insulin Consumption Forecast and Growth Rate (2022-2028)

    11 Global Insulin API Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Insulin API Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Insulin API Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Insulin API Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Insulin API Market Competitive Analysis

    • 14.1 Eli Lilly

      • 14.1.1 Eli Lilly Company Details

      • 14.1.2 Eli Lilly Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eli Lilly Insulin API Product and Service

    • 14.2 Tonghua Dongbao

      • 14.2.1 Tonghua Dongbao Company Details

      • 14.2.2 Tonghua Dongbao Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Tonghua Dongbao Insulin API Product and Service

    • 14.3 Sanofi-Aventis

      • 14.3.1 Sanofi-Aventis Company Details

      • 14.3.2 Sanofi-Aventis Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sanofi-Aventis Insulin API Product and Service

    • 14.4 Biocon

      • 14.4.1 Biocon Company Details

      • 14.4.2 Biocon Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Biocon Insulin API Product and Service

    • 14.5 Gan & Lee Pharmaceuticals

      • 14.5.1 Gan & Lee Pharmaceuticals Company Details

      • 14.5.2 Gan & Lee Pharmaceuticals Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Gan & Lee Pharmaceuticals Insulin API Product and Service

    • 14.6 United Laboratory

      • 14.6.1 United Laboratory Company Details

      • 14.6.2 United Laboratory Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 United Laboratory Insulin API Product and Service

    • 14.7 Yichang HEC Changjiang Pharmaceutical

      • 14.7.1 Yichang HEC Changjiang Pharmaceutical Company Details

      • 14.7.2 Yichang HEC Changjiang Pharmaceutical Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Yichang HEC Changjiang Pharmaceutical Insulin API Product and Service

    • 14.8 Amphastar

      • 14.8.1 Amphastar Company Details

      • 14.8.2 Amphastar Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Amphastar Insulin API Product and Service

    • 14.9 Bioton

      • 14.9.1 Bioton Company Details

      • 14.9.2 Bioton Insulin API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bioton Insulin API Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Insulin API

    • Figure Insulin API Picture

    • Table Global Insulin API Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Insulin API Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Insulin API Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Insulin API Consumption by Country (2017-2022)

    • Figure United States Insulin API Consumption and Growth Rate (2017-2022)

    • Table Europe Insulin API Consumption and Growth Rate (2017-2022)

    • Figure China Insulin API Consumption and Growth Rate (2017-2022)

    • Figure Japan Insulin API Consumption and Growth Rate (2017-2022)

    • Figure India Insulin API Consumption and Growth Rate (2017-2022)

    • Figure South Korea Insulin API Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin API Consumption Forecast by Country (2022-2028)

    • Figure United States Insulin API Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Insulin API Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Insulin API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Insulin API Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Insulin API Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Insulin API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Regular Human Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Analogue Consumption and Growth Rate (2017-2022)

    • Figure Global Short Acting Consumption and Growth Rate (2017-2022)

    • Figure Global Intermediate Acting Consumption and Growth Rate (2017-2022)

    • Figure Global Long Acting Consumption and Growth Rate (2017-2022)

    • Figure Global Pre-mix Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Regular Human Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Analogue Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Short Acting Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intermediate Acting Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Long Acting Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pre-mix Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Insulin API Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Insulin API Export by Region (Top 5 Countries) (2017-2028)

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Insulin API Product and Service

    • Table Tonghua Dongbao (Foundation Year, Company Profile and etc.)

    • Table Tonghua Dongbao Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tonghua Dongbao Insulin API Product and Service

    • Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-Aventis Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Insulin API Product and Service

    • Table Biocon (Foundation Year, Company Profile and etc.)

    • Table Biocon Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biocon Insulin API Product and Service

    • Table Gan & Lee Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Gan & Lee Pharmaceuticals Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gan & Lee Pharmaceuticals Insulin API Product and Service

    • Table United Laboratory (Foundation Year, Company Profile and etc.)

    • Table United Laboratory Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table United Laboratory Insulin API Product and Service

    • Table Yichang HEC Changjiang Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Yichang HEC Changjiang Pharmaceutical Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Yichang HEC Changjiang Pharmaceutical Insulin API Product and Service

    • Table Amphastar (Foundation Year, Company Profile and etc.)

    • Table Amphastar Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amphastar Insulin API Product and Service

    • Table Bioton (Foundation Year, Company Profile and etc.)

    • Table Bioton Insulin API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioton Insulin API Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US